Letter: choosing between ustekinumab and vedolizumab in anti-TNF refractory Crohn's disease-the devil is in the detail
| Image |  |
|---|---|
| Description | scientific article published on 01 August 2020 |
| Author/s | |
| Publication date | August 1, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |